Browse diseases

…utologous TCR-T targeting PRAME in patients with PD1 refractory metastatic melanoma. Abstract 2508. Presented at: ASCO Annual Meeting; June 2025; C…

…oroidal melanoma. Differential diagnosis included recurrence of choroidal melanoma, metastases from the cutaneous melanoma or pembrolizumab-associ…

…and orbit cancer (SIR, 2.96 (95% CI 2.55 to 3.41)), followed by cutaneous melanoma (SIR, 2.67 (95% CI 2.41 to 2.94)) and chronic lymphocytic leuka…

…oadjuvant settings for a number of solid malignancies including cutaneous melanoma as compared with adjuvant schemes. A key difference between bot…

…anuary 2003 to September 2022, 453 patients were diagnosed with malignant melanoma and were treated with immunotherapy or targeted therapy. The me…

…myeloid cells, coupled with secretion of PROS1 from reactivated melanoma cells in the aged metastatic lung and liver provides two mechan…

…red in 36.75% of patients, with certain cancer types, including cutaneous melanoma, bladder cancer, and lung cancers, showing the highest mutation…

…those at the highest risk of death. Patients with node-negative CM and a high-risk 31-GEP result may benefit from more intensive s…

…Conclusions Our research aims to understand how SOX10-deficient melanoma alters the composition and function of the tumor immune microen…

… predisposition syndrome (POT1-TPDS). These tumours may include cutaneous melanoma, angiosarcoma, haematological malignancy and brain tumours. Due…